Szabó Miklós

1.

Dojcsák, D., Kardos, Z., Szabó, M., Oláh, C., Körömi, Z., Viskolcz, B., Váradi, C.: The Alterations of Serum N-glycome in Response to SARS-CoV-2 Vaccination.
Int. J. Mol. Sci. 24 (7), 1-7, (article identifier: 6203), 2023.

doi DEA Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

2.

Szabó, M., Kardos, Z., Kostyál, L., Tamáska, P., Oláh, C., Csánky, E., Szekanecz, Z.: The importance of chest CT severity score and lung CT patterns in risk assessment in COVID-19-associated pneumonia: a comparative study.
Front. Med. 10, 1-9, (article identifier: 1125530), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

3.

Kardos, Z., Szabó, M., Baráth, Z., Miksi, Á., Oláh, C., Kozma, Á., Gergely, J. A., Csánky, E., Szekanecz, Z.: Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: a Single-centre Retrospective Controlled Study.
Biomedicines. 11 (2), 1-15, (article identifier: 349), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

4.

Dézsi, L., Mészáros, T., Kozma, G., H-Velkei, M., Oláh, C., Szabó, M., Patkó, Z., Fülöp, T., Hennies, M., Szebeni, M., Barta, B. A., Merkely, B., Radovits, T., Szebeni, J.: A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor.
GeroScience. 44 (2), 597-618, 2022.

doi DEA Scopus

Journal metrics:

Q1 Aging

Q1 Cardiology and Cardiovascular Medicine

D1 Complementary and Alternative Medicine

Q1 Geriatrics and Gerontology

D1 Veterinary (miscellaneous)

5.

Szabó, M., Sárközy, D., Szigeti, M., Farsang, R., Kardos, Z., Kozma, Á., Csánky, E., Chung, D. S., Szekanecz, Z., Guttman, A.: Introduction of a Capillary Gel Electrophoresis-Based Workflow for Biotherapeutics Characterization: size, Charge, and N-Glycosylation Variant Analysis of Bamlanivimab, an Anti-SARS-CoV-2 Product.
Front. Bioeng. Biotechnol. 10, 1-9, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Bioengineering

Q1 Biomedical Engineering

Q1 Biotechnology

Q2 Histology

6.

Szabó, M., Filep, C. B., Nagy, M., Sárközy, D., Szigeti, M., Sperling, E., Csánky, E., Guttman, A.: N-glycosylation structure - function characterization of omalizumab, an anti-asthma biotherapeutic product.
J. Pharm. Biomed. Anal. 209, 1-5, (article identifier: 114483), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Clinical Biochemistry

Q2 Drug Discovery

Q2 Pharmaceutical Science

Q2 Spectroscopy

7.

Szabó, M., Kardos, Z., Oláh, C., Tamáska, P., Hódosi, K., Csánky, E., Szekanecz, Z.: Severity and prognostic factors of SARS-CoV-2-induced pneumonia: the value of clinical and laboratory biomarkers and the A-DROP score.
Front. Med. 9, 1-8, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

8.

Szekanecz, Z., Szamosi, S., Szűcs, G., Kardos, Z., Szabó, M., Vályi-Nagy, I.: Tocilizumab a COVID-19 kezelésében.
Immunol. Szle. 14 (2), 5-10, 2022.

DEA

9.

Mészáros, B., Járvás, G., Farkas, A., Szigeti, M., Kovács, Z., Kun, R., Szabó, M., Csánky, E., Guttman, A.: Comparative analysis of the human serum N-glycome in lung cancer, COPD and their comorbidity using capillary electrophoresis.
J. Chromatogr. B. 1137, 1-7, 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q3 Biochemistry

Q3 Cell Biology

Q2 Clinical Biochemistry

Q2 Medicine (miscellaneous)

10.

Elek, Z., Kovács, Z., Keszler, G., Szabó, M., Csánky, E., Luo, J., Guttman, A., Rónai, Z.: High Throughput Multiplex SNP-analysis In Chronic Obstructive Pulmonary Disease and Lung Cancer.
Curr. Mol. Med. 20 (3), 185-193, 2020.

doi DEA

Journal metrics:

Q3 Biochemistry

Q2 Medicine (miscellaneous)

Q4 Molecular Biology

Q3 Molecular Medicine

11.

Oláh, M., Kresznerits, S., Gonda, X., Perczel-Forintos, D., Szabó, M., Csánky, E., Meszáros, Á.: Impact of education on dimensions of adherence in patients with chronic obstructive pulmonary disease.
Acta Poloniae Pharmaceutica - Drug Research. 77 (1), 195-204, 2020.

doi DEA WoS Scopus

Journal metrics:

Q4 Pharmacology

Q3 Pharmaceutical Science

12.

Mészáros, B., Járvás, G., Kun, R., Szabó, M., Csánky, E., Abonyi, J., Guttman, A.: Machine Learning Based Analysis of Human Serum N-glycome Alterations to Follow up Lung Tumor Surgery.
Cancers (Basel). 12 (12), 1-13, 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

13.

Farkas, A., Mészáros, B., Szarka, M., Szigeti, M., Kappelmayer, J., Szabó, M., Csánky, E., Guttman, A.: Modeling of the Desialylated Human Serum N-glycome for Molecular Diagnostic Applications in Inflammatory and Malignant Lung Diseases.
Curr. Mol. Med. 20 (10), 765-772, 2020.

doi DEA

Journal metrics:

Q3 Biochemistry

Q2 Medicine (miscellaneous)

Q4 Molecular Biology

Q3 Molecular Medicine

14.

Szabó, M., Kun, R., Hajba, L., Koncz, R., Guttman, A., Csánky, E.: Protein és glikán biomarkerek szerepe a krónikus obstruktív tüdőbetegség diagnosztikájában.
Orv. hetil. 161 (4), 123-128, 2020.

doi DEA WoS Scopus

Journal metrics:

Q4 Medicine (miscellaneous)

15.

Szabó, M., Hajba, L., Kun, R., Guttman, A., Csánky, E.: Proteomic and Glycomic Markers to Differentiate Lung Adenocarcinoma from COPD.
Curr. Med. Chem. 27 (20), 3302-3313, 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q1 Drug Discovery

Q2 Molecular Medicine

Q1 Organic Chemistry

Q2 Pharmacology

16.

Magorivska, I., Döncző, B., Dumych, T., Karmash, A., Boichuk, M., Hychka, K., Mihalj, M., Szabó, M., Csánky, E., Rech, J., Guttman, A., Vári, S. G., Bilyy, R.: Glycosylation of random IgG distinguishes seropositive and seronegative rheumatoid arthritis.
Autoimmunity. 51 (3), 111-117, 2018.

doi DEA WoS Scopus

Journal metrics:

Q3 Immunology

Q2 Immunology and Allergy

17.

Szabó, M., Jáger, M., Krizsó, E., Gilányi, I., Leny, A., Szűcs, G., Csánky, E.: Chylothorax mint a coronaria-bypassműtét szövődménye = Chylothorax as a complication of coronary artery bypass grafting operation.
Orv. hetil. 153 (14), 553-558, 2012.

doi DEA Scopus

Journal metrics:

Q3 Medicine (miscellaneous)

Publication list